Skip to main content
. 2024 Apr 18;38(6):3212–3222. doi: 10.1007/s00464-024-10827-6

Table 1.

shows demographics for the patients in the development series, for all patients (inclusive of validation subgroup) and only for the validation subgroup

Patient and analysis data
All Development series Validation subgroup
N 23 14 9
Mean age 63.91 65.6 61.44
Male: female 16:07 12:02 04:05
Cancer: benign 15:08 09:05 06:03
T Stage T4(3) T3(5) T2(5) T1(2) T4(2) T3(4) T2(2) T1(1) T4(1) T3(1) T2(3) T1(1)
Left: right 15:08 08:06 07:02
Extracorporeal: intracorporeal 21:02 12:02 9:00
Bowel continuity restored 22 of 23 13 of 14 9 of 9
Large: small bowel analysis 23:07 14:05 09:02